PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells

Engineering & Materials Science

• Milk 100%
• RNA 90%
• Transcription 87%
• Polyetherimides 75%
• Nanoparticles 74%
• Cells 73%
• Transducers 70%
• Coulomb interactions 7%
• Chemotherapy 7%
• Cell death 7%
• Cytotoxicity 7%
• Polymers 7%
• Cell growth 7%
• Zeta potential 7%
• Oncology 6%
• Fluorescence 5%
• Transmission electron microscopy 5%
• Evaporation 4%
• Chemical activation 4%
• Trajectories 3%

Medicine & Life Sciences

• Polylactic Acid-Polyglycolic Acid Copolymer 96%
• Paclitaxel 76%
• Nanoparticles 66%
• Lung Neoplasms 59%
• RNA 52%
• A549 Cells 33%
• Neoplasms 12%
• Polymers 8%
• Polyethyleneimine 6%
• Tubulin 5%
• Transmission Electron Microscopy 5%
• Microtubules 4%
• Antineoplastic Agents 4%
• Transcriptional Activation 4%
• Cytoplasm 4%
• Therapeutics 4%
• Fluorescence 4%
• Drug Therapy 2%
• Mutation 2%
• Growth 2%
• In Vitro Techniques 2%

Chemical Compounds

• Paclitaxel 90%
• Resistance 47%
• Nanoparticle 37%
• Yellowish 6%
• Solvent Evaporation 5%
• Antitumor 4%
• Antineoplastic Agent 4%
• Zeta Potential 4%
• Mutation 4%
• Green 3%
• Transmission Electron Microscopy 3%
• Fluorescence 2%
• Surface 1%